- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06566495
Microorganisms on Reusable Tourniquets
Reusable Tourniquets as Potential Risk of Microbial Transmission - Comparison of Operating Theatre and Emergency Department
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The cross-sectional study was conducted in the operating theater and emergency department of a tertiary referral hospital in Gdansk, Poland, in three part from March to April 2024. The study included reusable tourniquets used by the hospital's medical staff during vascular access generation.
After each stage of the in-hospital study, the stasis was collected and replaced with new ones. A total of 53 reusable stasis were collected in three phases of the study and were subjected to microbiological analysis at the Department of Immunobiology and Environmental Microbiology of the Medical University of Gdansk. The tourniquets were collected into disposable, sterile bags. In the first stage of the study, tourniquets were collected of indefinite use (n= 17). In the second and third stages of the study, stasis used for 14 (n=20) and 28 (n=16) days, respectively, were collected. All tourniquets were labeled and assigned to different rooms located within the surveyed wards. The trial was conducted separately, for the plastic fastener and the fabric band. The plastic parts of the tourniquets were placed in sterile glass dishes. Under laboratory conditions, the plastic parts of the stasis were cut off and placed in the dishes. Using sterile swabs soaked in 0.9% sodium chloride, the plastic was swabbed, after which the tip of the swab was cut off, placed in a tube with 0.9% sodium chloride (3ml), which was shaken in a Vortex device (30 seconds) and the obtained material was seeded on columbia Agar with 5% sheep blood. The material part of the stasis was placed in a sterile homogenization bag with the addition of 100ml of nutrient broth. The bag was then placed in a Stomacher Homogenizer for two minutes to detach the microorganisms from the porous surface of the material. The resulting homogenate was transferred in a concentrated state and diluted tenfold using 200 μl pipettes onto columbia Agar media supplemented with 5% sheep blood.200 μl of concentrated homogenate was seeded onto the quality growth media MacConkey Broth, King B Agar, CHROMagar E. coli and other coliforms. The protected material was incubated for 24 hours at 37°C, in an aerobic atmosphere. After this time, bacterial colonies were counted and counts were performed to determine the number of microorganisms on the surface of the stasis (CFU/cm2). Due to the assumptions of the experiment and the time frame, eight tourniquets were not included in the analysis. From the information obtained from the medical staff, this was due to significant soiling, making it impossible to use the tourniquets, and in a few cases the plastic fastener broke.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Dębinki Street
-
Gdańsk, Dębinki Street, Poland, 80-211
- Medical Univeristy of Gdańsk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- reusable tourniquets used to make the vessel visible
Exclusion Criteria:
- disposable tourniquets used to make the vessel visible
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
reusable tourniquets used by indefinite time
6 tourniquets from emergency department and 11 tourniquets from operating theatre
|
Microbiological analysis The material was collected in each group in the same way.
Other Names:
|
|
reusable tourniquets used by 14 days
6 tourniquets from emergency department and 14 tourniquets from operating theatre
|
Microbiological analysis The material was collected in each group in the same way.
Other Names:
|
|
reusable tourniquets used by 28 days
6 tourniquets from emergency department and 10 tourniquets from operating theatre
|
Microbiological analysis The material was collected in each group in the same way.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standard Deviation and median of colony forming units (CFU/cm2) in the emergency department
Time Frame: 24 hours
|
After 24h incubation at 37 deg C, we evaluated the number of bacterial colony-forming colonies on leaf and quality plates.
The average number of CFU/cm2 in all stages of the study for the emergency department is 19,110, 34 CFU/cm2.
For the MCC substrate for the emergency department medium 227.65; standard deviation 102.75 CFU/cm2.
For the King B substrate for the emergency department medium 241.71, standard deviation 115.15 18 CFU/cm2.
There is no statistically significant difference for OD versus CFU/cm2 during the second and third intake.
There were no bacterial growth was obtained on the ECC plate.
|
24 hours
|
|
Standard Deviation and median of colony forming units (CFU/cm2) in the operating theatre
Time Frame: 24 hours
|
After 24h incubation at 37 deg C, we evaluated the number of bacterial colony-forming colonies on leaf and quality plates.
The average number of CFU/cm2 in all stages of the study for the operating theatre was 88.27 CFU/cm2.
For the MCC substrate for the operating theatre medium 14.18 standard deviation 24.06 CFU/cm2.
For the King B substrate for the operating theatre medium 33.07 standard deviation 65.18 CFU/cm2.There is no statistically significant difference for OD versus CFU/cm2 during the second and third intake.
There were no bacterial growth was obtained on the ECC plate.
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood stains and CFU
Time Frame: 2 months
|
23 of 53 examined tourniquets (43%), 12/18 (67%) from the emergency department and 11/35 (31%) from the operating theatre had visible blood stains.
Blood stains did not affect the number of colony-forming units (CFUs).
|
2 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KB/45/2024
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microbial Colonization
-
Karolinska InstitutetCompletedMicrobial Colonization and Colorectal Disease
-
Pamukkale UniversityCompletedOral Microbial Colonization | Periodontal Health | Periodontal ParametersTurkey (Türkiye)
-
NHS FifeUniversity of TurkuUnknownDental Caries | Oral Microbial ColonizationUnited Kingdom
-
University Magna GraeciaRecruiting
-
Medical University InnsbruckCompleted
-
Christine ZürcherCompleted
-
Asan Medical CenterNot yet recruitingMicrobial Colonization
-
Professor Klaus BønnelykkeRecruitingMicrobial ColonizationDenmark
-
BLIS Technologies LimitedRecruitingMicrobial ColonizationNew Zealand
-
BLIS Technologies LimitedRecruiting
Clinical Trials on collection of microbiological material from reusable tourniquets
-
Azienda USL Reggio Emilia - IRCCSEuropean Union; Ministero della Salute, ItalyRecruitingMultiple Myeloma (MM) | Monoclonal Gammopathy of Undetermined Significance (MGUS) | Smoldering Multiple Myeloma (SMM)Italy
-
University of Campania Luigi VanvitelliCompleted
-
Duke UniversityGenentech, Inc.TerminatedPrimary Open Angle Glaucoma | Glaucoma | Glaucoma, SuspectUnited States
-
Universitaire Ziekenhuizen KU LeuvenRecruitingSkin Cancer, Non-Melanoma | Skin Cancer MelanomaBelgium
-
University Hospital Inselspital, BerneCompletedCOVID-19Switzerland
-
IRCCS San RaffaeleRecruitingRheumatic Diseases | Pregnancy Complications | Pregnancy, High Risk | Preeclampsia | Immunologic Disease | Antiphospholipid Antibody Syndrome PrimaryItaly
-
IRCCS San RaffaeleRecruiting
-
Trakya UniversityCommission of Scientific Research Projects of Trakya University (TÜBAP)CompletedEarly Childhood CariesTurkey
-
Assistance Publique - Hôpitaux de ParisRecruitingFMR1 Gene PremutationFrance
-
Central Hospital, Nancy, FranceUniversity of LorraineUnknownGender Dysphoria